Is Treatment Free in a Clinical Trial? — What Is Covered and What Is Not

Partly. The investigational drug itself is normally supplied free by the sponsor, and so are the tests done only because the trial requires them. Care you would have needed anyway is usually still billed to you. Travel and incidental costs may be reimbursed, within an amount the ethics committee has approved.

Almost nobody searches for a trial because they want to advance science. They search because a treatment has been named, the price has been said out loud, and a trial is the only route to it that does not end in selling something. So this page answers the money question first, in the order families actually ask it — what is covered, what is not, and whether the bus fare comes back.

This page is informational, not a recruitment page. It explains how trial costs are structured in India. It does not offer a trial, does not enrol anyone, and cannot promise a place in any study. Eligibility is decided by screening at the trial site, and most people who enquire about a specific study do not meet its criteria.

The study drug, the tests and scans done only because the protocol demands them, and the extra clinic visits the trial adds to your calendar. Sponsors also carry the cost of treating any injury caused by the trial, and must hold insurance covering participants. Nothing outside the protocol is automatically covered.

• The investigational drug. Supplied free for the period the protocol specifies. This is the single largest cost a trial removes, and it is the reason the word “free” attaches itself to trials in the first place.
• Protocol-only tests and imaging. Extra blood work, extra scans, biomarker testing done for the study, questionnaires, ECGs — anything the protocol adds beyond normal care. At CION, response-assessment PET-CT is coordinated at partner imaging centres rather than owned in-house, and any trial you join will have its own imaging arrangements, so ask the site where each scan is done and who is billed for it.
• The additional visits. Trials usually require you at the hospital more often than routine treatment would. Consultation and procedure charges for those extra protocol visits sit with the sponsor.
• Medical management of a trial-related injury. Under the New Drugs and Clinical Trials Rules, 2019, this must be provided free of charge for as long as it is required, with financial compensation payable where injury or death is found to be related to the trial.
• Insurance covering participants. Sponsors are required to hold it. Ask to see the confirmation rather than assuming it exists.
• Reimbursement approved by the ethics committee. Where the committee has approved it, travel, incidental costs and lost wages are reimbursed at the fixed amount — not at whatever you actually spent.

One warning about language. A drug being supplied free says nothing about whether it works for you. It is investigational precisely because that is not yet settled, which is what the study is for. Trial Phases Explained: Phase 1, 2 and 3 sets out how much is known at each stage — and it is far less in an early-phase study than most families assume.

Everything you would have needed even if the trial did not exist. Hospital registration and admission charges, standard investigations, supportive medicines, treatment for your other illnesses, and getting to the site and staying near it. Screening tests before acceptance are sometimes charged. Ask before screening starts.

• Routine hospital charges. Registration, consultation outside protocol visits, day-care or admission charges for care you would have received anyway. A trial is layered on top of your usual treatment; it does not replace the bill for it.
• Standard investigations. The bloods, scans and reviews that are part of ordinary cancer care remain ordinary cancer care, even while you are on a study. Ask for the split in writing.
• Supportive and side-effect medicines. Anti-emetics, steroids, antibiotics, pain relief and the rest are frequently the participant’s cost. A few protocols cover them. Do not assume yours does.
• Your other conditions. Diabetes, blood pressure, thyroid, cardiac care and everything else you take medicines for stays with you and your usual doctor.
• Staying near the site. Reimbursement covers travel and incidentals at an approved rate. It rarely covers weeks of accommodation for a family that has moved cities for treatment, which is the cost that most often ends a trial early.
• Screening, in some studies. The tests that decide whether you are eligible are sometimes paid by the sponsor and sometimes not, and screening does not always end in acceptance. Settle this before the first sample is drawn.
• The time itself. More visits means more days off, more bus and train fares, and more days an attendant cannot work. Put a real number on that before you sign, because nobody at the site will do it for you.

If you have Aarogyasri, CGHS, ECHS, ESI or a private policy, ask the trial site how the routine part of your care will be billed while you are on study. Joining a trial does not automatically change how those claims are processed, and the answer differs between hospitals.

Often, but within limits. The ICMR National Ethical Guidelines permit reimbursement of travel, wages lost and incidental expenses. The ethics committee reviewing the study fixes the amount and keeps it modest, so payment cannot become the reason a person agrees to take part. Ask what has been approved for your study.

• It is reimbursement, not payment. The purpose is that taking part should not leave you poorer. It is not a fee for participating, and it is not compensation for risk.
• The ethics committee sets the ceiling. A committee registered with the licensing authority reviews and approves the amount as part of approving the study. The site cannot quietly increase it, and should not quietly reduce it either.
• Ask the three practical questions. How much is approved per visit, what paperwork or receipts you must produce, and how long payment usually takes. Vague answers to any of the three are worth noticing.
• Check it against the Participant Information Sheet. What you are told verbally and what the document says should be identical. If they are not, the document is what counts.
• Wages lost can be included. Where the committee has approved it, a day’s lost earnings for the participant, and sometimes for one accompanying person, can be reimbursed. Ask specifically rather than assuming.
• Accommodation is the usual gap. Reimbursement is built around visit-day travel. Families relocating for months of treatment rarely find it covers what they are actually spending.

The sponsor. Under the New Drugs and Clinical Trials Rules, 2019, medical management of an injury related to the trial must be provided free of charge for as long as it is needed, and financial compensation is payable where injury or death is found to be trial-related. Sponsors must also hold insurance covering participants.

This is one of the genuine protections Indian trial regulation gives participants, and it is also the part families most often do not know exists. It is worth reading the injury section of the consent document as carefully as the cost section — because the two are connected. A serious side effect that needs weeks of hospital care is a cost question as much as a medical one.

• Ask who to call, at any hour. Get a name and a number that works at 2am, and put it in the same pocket as your hospital card.
• Ask what the site does first. Whether you are treated at the trial site, at the nearest emergency department, or wherever you happen to be, and who coordinates it.
• Ask how a claim is made. The ethics committee and the licensing authority are involved in deciding whether an injury is related to the trial. Understand the route before you need it.
• Ask what is not covered. Harm caused by your cancer itself, or by care unrelated to the study, sits outside this protection. The consent document should say so plainly.

This is exactly the ground that What Informed Consent for a Trial Actually Means covers in detail — consent is a process you can pause, question and walk away from, not a form you sign at a desk.

Seven steps, in this order: find the trial on CTRI, get your oncologist to refer you, ask for the Participant Information Sheet, read the cost section line by line, confirm the approved reimbursement, confirm who pays for trial-related injury, and ask what happens when the study ends.

1. 1

   Find the trial on CTRI, not on social media

   Every trial legally running in India must be registered with the Clinical Trials Registry - India (CTRI), maintained by ICMR. The registry entry names the sponsor, the participating sites and a contact. If a study you have been told about is not there, treat that as your answer.

2. 2

   Ask your treating oncologist to make the referral

   Sites screen patients; patients do not enrol themselves. Your oncologist can send your reports to the site and ask two things: whether recruitment is still open, and whether you fit the criteria on paper. This costs nothing and saves a wasted journey.

3. 3

   Ask for the Participant Information Sheet before you travel

   Every approved study has one, written in plain language and available in the local language. It must set out what the sponsor pays for and what you pay for. Read it at home, with family, not in a corridor on the day.

4. 4

   Read the cost section line by line

   Look for three separate groups: the study drug, the tests done only for the trial, and the tests you would have had anyway. The third group is where families are caught out, because it usually stays on your bill.

5. 5

   Ask what reimbursement is approved, and how it is claimed

   Travel, lost wages and incidental expenses may be reimbursed if the ethics committee has approved it. Ask the amount, whether receipts are needed, who to submit them to, and how long payment takes. Ask for it in writing.

6. 6

   Ask who pays if you are harmed, and what happens first

   Under the New Drugs and Clinical Trials Rules, 2019, medical management of a trial-related injury is free for as long as it is needed, and compensation is payable where injury or death is found to be trial-related. Ask for the number to call at any hour.

7. 7

   Ask what happens when the trial ends, or if you walk away

   You may withdraw at any time, without giving a reason and without losing your usual care. Before you sign, ask whether the drug continues once the study closes, who would pay for it then, and what the plan is if you leave early.

It does not mean the treatment works, that you will receive the new drug, or that a place is available. A trial exists because the answer is not yet known. Free supply is a fact about funding, not about benefit — and no hospital can guarantee you entry to a study.

• Investigational means unproven. The study is being run to find out whether the treatment helps and how safe it is. Anyone describing a trial drug as a certainty for you is describing something the trial itself has not established.
• You may not receive the new drug. Many trials randomise participants between the investigational arm and standard care. Will I Get a Placebo in a Cancer Trial? explains what is actually used in cancer studies, and why a bare sugar pill in place of treatment is not how modern cancer trials are designed.
• Nobody can guarantee enrolment. Eligibility criteria are strict, screening decides, and recruitment closes once the required number is reached. Treat any promise of a place — from a hospital, an agent or a website — as a reason to step back.
• The saving is real but partial. Removing the drug cost from the bill can be the difference between treatment and no treatment for a family. It still leaves travel, routine care and time to be paid for.
• You can leave. Withdrawing at any point, without giving a reason, does not cost you your usual care. Ask before you sign what your treatment would revert to if you did.
• Ask about the option of not treating. For some situations, best supportive care is a legitimate choice rather than a failure, and it should be discussed openly alongside a trial rather than as a last resort.

Cost is the first question but rarely the last. What families ask next is whether they might be given a placebo, how much is known at each phase, what they are actually agreeing to at consent, and where immunotherapy fits overall. These four pages answer those in that order.

• Will I Get a Placebo in a Cancer Trial? — what comparison arms in cancer studies really contain, and what randomisation would mean for you.
• Trial Phases Explained: Phase 1, 2 and 3 — how much is known at each stage, and why an early-phase study answers a different question from a late-phase one.
• What Informed Consent for a Trial Actually Means — the document, the conversation, and the right to stop at any point without losing your care.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment and monitoring fit together as one pathway.

No Rushed Decisions. No Promises We Cannot Keep.

Every plan is reviewed by a tumour board, and every family is told what is certain and what is not before treatment starts.